Evidence for Use or Disuse of Renin–Angiotensin System Modulators in Patients Having COVID-19 With an Underlying Cardiorenal Disorder
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evidence for Use or Disuse of Renin–Angiotensin System Modulators in Patients Having COVID-19 With an Underlying Cardiorenal Disorder
Authors
Keywords
-
Journal
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
Volume 25, Issue 4, Pages 299-306
Publisher
SAGE Publications
Online
2020-04-30
DOI
10.1177/1074248420921720
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
- (2020) Jin-jin Zhang et al. ALLERGY
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
- (2020) Hussin A. Rothan et al. JOURNAL OF AUTOIMMUNITY
- Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS
- (2020) Yushun Wan et al. JOURNAL OF VIROLOGY
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
- (2020) Wenhua Liang et al. LANCET ONCOLOGY
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- COVID-19 and the cardiovascular system
- (2020) Ying-Ying Zheng et al. Nature Reviews Cardiology
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia
- (2020) Fengxiang Song et al. RADIOLOGY
- Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2
- (2020) Renhong Yan et al. SCIENCE
- Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury
- (2020) Yingxia Liu et al. Science China-Life Sciences
- Transmission routes of 2019-nCoV and controls in dental practice
- (2020) Xian Peng et al. International Journal of Oral Science
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
- (2020) Xiaobo Yang et al. Lancet Respiratory Medicine
- The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2
- (2020) Liang Chen et al. CARDIOVASCULAR RESEARCH
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China
- (2020) Zhongliang Wang et al. CLINICAL INFECTIOUS DISEASES
- SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?
- (2020) Gabriela M Kuster et al. EUROPEAN HEART JOURNAL
- Antihypertensive treatment with ACEI/ARB of patients with COVID-19 complicated by hypertension
- (2020) Gang Li et al. HYPERTENSION RESEARCH
- Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?
- (2020) Murray Esler et al. JOURNAL OF HYPERTENSION
- Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19
- (2020) James H Diaz JOURNAL OF TRAVEL MEDICINE
- Kidney disease is associated with in-hospital death of patients with COVID-19
- (2020) Yichun Cheng et al. KIDNEY INTERNATIONAL
- The Novel Coronavirus 2019 epidemic and kidneys
- (2020) Saraladevi Naicker et al. KIDNEY INTERNATIONAL
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic
- (2020) Andrew M. South et al. Nature Reviews Nephrology
- Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington
- (2020) Temet M. McMichael et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
- (2020) Muthiah Vaduganathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives
- (2020) Jiumeng Sun et al. TRENDS IN MOLECULAR MEDICINE
- Drugs and the renin-angiotensin system in covid-19
- (2020) Jeffrey K Aronson et al. BMJ-British Medical Journal
- Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
- (2020) Lei Fang et al. Lancet Respiratory Medicine
- Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers
- (2020) Chirag Bavishi et al. JAMA Cardiology
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
- (2020) Jia Liu et al. Cell Discovery
- Renin-Angiotensin System Blockers and the COVID-19 Pandemic
- (2020) A.H. Jan Danser et al. HYPERTENSION
- Angiotensin-(1–7), Adipokines and Inflammation
- (2019) Deborah Farias Lelis et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Concurrent neprilysin inhibition and renin-angiotensin system modulations prevented diabetic nephropathy
- (2019) Vajir Malek et al. LIFE SCIENCES
- The ACE2/Angiotensin-(1–7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1–7)
- (2018) Robson Augusto Souza Santos et al. PHYSIOLOGICAL REVIEWS
- Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease
- (2018) Jay Ramchand et al. PLoS One
- Fiend and friend in the renin angiotensin system: An insight on acute kidney injury
- (2018) Nisha Sharma et al. BIOMEDICINE & PHARMACOTHERAPY
- The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases
- (2017) Xiao C. Li et al. PHARMACOLOGICAL RESEARCH
- The Spike Protein of the Emerging Betacoronavirus EMC Uses a Novel Coronavirus Receptor for Entry, Can Be Activated by TMPRSS2, and Is Targeted by Neutralizing Antibodies
- (2013) S. Gierer et al. JOURNAL OF VIROLOGY
- Role of the Spike Glycoprotein of Human Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Virus Entry and Syncytia Formation
- (2013) Zhaohui Qian et al. PLoS One
- A hexapeptide of the receptor-binding domain of SARS corona virus spike protein blocks viral entry into host cells via the human receptor ACE2
- (2012) Anna-Winona Struck et al. ANTIVIRAL RESEARCH
- Angiotensin-Converting Enzyme 2 (ACE2) in Disease Pathogenesis
- (2010) Yumiko Imai et al. CIRCULATION JOURNAL
- SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS
- (2009) G. Y. Oudit et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now